FDA Adverse Event Malfunction Summary report: N

BIOGRAFT

MDR report key: 204716 · Received December 31, 1998

Report

Report Number
2183620-1998-00012
Event Type
Malfunction
Date Received
December 31, 1998
Date of Event
October 28, 1998
Report Date
December 30, 1998
Manufacturer
BIO-VASCULAR, INC.
Product Code
LXA
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
GM
Reporter Occupation
PHYSICIAN

Narratives

Description of Event or Problem · 1

THE SURGEON REPORTED THAT ON 10/28/98, THE PT WAS BEING TREATED FOR SEVERE CLAUDICATION, FOOT ULCER. A FEMORO-CRURAL VEIN RECONSTRUCTION BYPASS PROCEDURE WAS PERFORMED UTILIZING THE BIOGRAFT. AFTER COMPLETING THE DISTAL VASCULAR SUTURE, THE BYPASS WAS PULLED UP TO ABOVE THE KNEE JOINT WHEN THE BYPASS SUDDENLY GAVE WAY AND IN THE MIDDLE THIRD OF THE GRAFT, A 4CM LONG LACERATION COULD BE PALPATED. AT THIS POINT THE BYPASS WAS INTERRUPTED AND IT BECAME OBVIOUS THAT THE LACERATION WAS SITUATED AT THE SUTURE LINE OF THE TWO GRAFTS. SEVERAL LONGITUDINAL TEARS COULD BE OBSERVED. THE SURGEON RESECTED THE LESIONED GRAFT AND REGRAFTED WITH ANOTHER BIOGRAFT DEVICE. A SECTION OF THE EXPLANTED BIOGRAFT WAS RETURNED TO BIO-VASCULAR, INC. FOR ANALYSIS. THE SECOND BIOGRAFT IMPLANT IS PATENT AND THE PT HAS EXPERIENCED NO INFECTION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 BIOGRAFT Implant UMBILICAL VEIN GRAFT LXA BIO-VASCULAR, INC. 407505 2-8B16-0220

Patients

Seq Age Sex Outcome Treatment
1 57 YR Required Intervention